Does TOREMIFENE Cause Interstitial lung disease? 5 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Interstitial lung disease have been filed in association with TOREMIFENE (Fareston). This represents 2.0% of all adverse event reports for TOREMIFENE.
5
Reports of Interstitial lung disease with TOREMIFENE
2.0%
of all TOREMIFENE reports
1
Deaths
1
Hospitalizations
How Dangerous Is Interstitial lung disease From TOREMIFENE?
Of the 5 reports, 1 (20.0%) resulted in death, 1 (20.0%) required hospitalization.
Is Interstitial lung disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TOREMIFENE. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does TOREMIFENE Cause?
Fatigue (19)
Drug ineffective (17)
General physical health deterioration (14)
Atrial fibrillation (13)
Nausea (12)
Endometrial hyperplasia (10)
Hepatic function abnormal (10)
Oedema peripheral (10)
Drug-induced liver injury (9)
Endometrial thickening (9)
What Other Drugs Cause Interstitial lung disease?
METHOTREXATE (3,049)
RITUXIMAB (2,458)
PEMBROLIZUMAB (2,113)
PREDNISONE (1,850)
CYCLOPHOSPHAMIDE (1,725)
NIVOLUMAB (1,538)
AMIODARONE (1,421)
DOXORUBICIN (1,352)
ETANERCEPT (1,267)
ADALIMUMAB (1,250)
Which TOREMIFENE Alternatives Have Lower Interstitial lung disease Risk?
TOREMIFENE vs TORIPALIMAB
TOREMIFENE vs TORSEMIDE
TOREMIFENE vs TOVIAZ
TOREMIFENE vs TOVORAFENIB
TOREMIFENE vs TOZINAMERAN